SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-20-188892
Filing Date
2020-07-07
Accepted
2020-07-07 17:28:11
Documents
10
Effectiveness Date
2020-07-07

Document Format Files

Seq Description Document Type Size
1 S-3ASR d947886ds3asr.htm S-3ASR 473132
2 EX-1.2 d947886dex12.htm EX-1.2 198114
3 EX-4.4 d947886dex44.htm EX-4.4 251707
4 EX-4.5 d947886dex45.htm EX-4.5 271482
5 EX-5.1 d947886dex51.htm EX-5.1 15138
6 EX-5.2 d947886dex52.htm EX-5.2 8318
7 EX-23.1 d947886dex231.htm EX-23.1 1818
8 GRAPHIC g947886g0702132222307.jpg GRAPHIC 2742
9 GRAPHIC g947886g0702132530338.jpg GRAPHIC 2744
10 GRAPHIC g947886g11a65.jpg GRAPHIC 54195
  Complete submission text file 0001193125-20-188892.txt   1303259
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-239734 | Film No.: 201016748
SIC: 2834 Pharmaceutical Preparations